Drugs / Rimostil
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00030147 | Feb 2002 → Jun 2015 | depressive disorder | National Institute of Mental Health (NIMH) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rimostil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00030147 ↗ |
| Modality | Other / unclassified | “a proprietary phytoestrogen compound, Rimostil (1,000 mg twice/d)” PMID 33470755 ↗ Jan 2021 |
| Route | Oral | “1000 mg twice a day administered orally” NCT00030147 ↗ |